These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 3776429)
1. [Concentration of prolactin in the plasma of schizophrenic patients with positive and negative symptoms]. Prasad AD Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(9):1400-1. PubMed ID: 3776429 [TBL] [Abstract][Full Text] [Related]
3. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients. Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918 [TBL] [Abstract][Full Text] [Related]
4. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline]. Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F Encephale; 2003; 29(2):172-80. PubMed ID: 14567169 [TBL] [Abstract][Full Text] [Related]
5. Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women. Muck-Seler D; Pivac N; Mustapic M; Crncevic Z; Jakovljevic M; Sagud M Psychiatry Res; 2004 Jul; 127(3):217-26. PubMed ID: 15296821 [TBL] [Abstract][Full Text] [Related]
6. Serum prolactin levels in unmedicated first-episode and recurrent schizophrenia patients: a possible marker for the disease's subtypes. Segal M; Avital A; Rojas M; Hausvater N; Sandbank S; Liba D; Moguillansky L; Tal I; Weizman A Psychiatry Res; 2004 Jul; 127(3):227-35. PubMed ID: 15296822 [TBL] [Abstract][Full Text] [Related]
7. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS]. Loas G; Noisette C; Legrand A; Delahousse J Encephale; 1997; 23(1):10-8. PubMed ID: 9172962 [TBL] [Abstract][Full Text] [Related]
8. Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia. Petronijević ND; Radonjić NV; Ivković MD; Marinković D; Piperski VD; Duricić BM; Paunović VR Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1921-6. PubMed ID: 18824063 [TBL] [Abstract][Full Text] [Related]
16. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients. Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017 [TBL] [Abstract][Full Text] [Related]
17. Association between major Multidrug Resistance 1 (MDR1) gene polymorphisms and plasma concentration of prolactin during risperidone treatment in schizophrenic patients. Yasui-Furukori N; Tsuchimine S; Saito M; Nakagami T; Sato Y; Kaneko S Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1230-4. PubMed ID: 17559997 [TBL] [Abstract][Full Text] [Related]
18. Comparison of prolactin concentrations between haloperidol and risperidone treatments in the same female patients with schizophrenia. Yasui-Furukori N; Kondo T; Suzuki A; Mihara K; Kaneko S Psychopharmacology (Berl); 2002 Jun; 162(1):63-6. PubMed ID: 12107619 [TBL] [Abstract][Full Text] [Related]
19. Plasma prolactin concentrations and psychopathology in chronic schizophrenia. Kleinman JE; Weinberger DR; Rogol AD; Bigelow LB; Klein ST; Gillin JC; Wyatt RJ Arch Gen Psychiatry; 1982 Jun; 39(6):655-7. PubMed ID: 6979991 [TBL] [Abstract][Full Text] [Related]
20. [Incidence of the deficit form in refractory schizophrenia]. Samuelian JC Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]